SLC4A3 — Solute Carrier Family 4 Member 3 (Anion Exchanger 3)

Migration, Crosslink

📖

SLC4A3 — Solute Carrier Family 4 Member 3 (Anion Exchanger 3)

active

wiki page Created: 2026-04-02T07:19:16 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-slc4a3

📖 Wiki Page

gene2010 wordssynced 2026-04-02

SLC4A3 — Solute Carrier Family 4 Member 3 (Anion Exchanger 3)

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">SLC4A3 — Anion Exchanger 3 (AE3)</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>SLC4A3</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Solute Carrier Family 4 Member 3</td>
</tr>
<tr>
<td class="label">Alternative Names</td>
<td>AE3, Anion Exchanger 3, Band 3-like protein</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>2q35</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/6508" target="_blank">6508</a></td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>1,237 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~130 kDa</td>
</tr>
<tr>
<td class="label">Protein Class</td>
<td>Anion transporter (SLC4A family)</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>P48745</td>
</tr>
<tr>
<td class="label">Tissue Expression</td>
<td>Brain (neurons, glia), heart, retina, inner ear</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

SLC4A3 — Solute Carrier Family 4 Member 3 (Anion Exchanger 3)

Overview

...

SLC4A3 — Solute Carrier Family 4 Member 3 (Anion Exchanger 3)

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">SLC4A3 — Anion Exchanger 3 (AE3)</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>SLC4A3</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Solute Carrier Family 4 Member 3</td>
</tr>
<tr>
<td class="label">Alternative Names</td>
<td>AE3, Anion Exchanger 3, Band 3-like protein</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>2q35</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/6508" target="_blank">6508</a></td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>1,237 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~130 kDa</td>
</tr>
<tr>
<td class="label">Protein Class</td>
<td>Anion transporter (SLC4A family)</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>P48745</td>
</tr>
<tr>
<td class="label">Tissue Expression</td>
<td>Brain (neurons, glia), heart, retina, inner ear</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

SLC4A3 — Solute Carrier Family 4 Member 3 (Anion Exchanger 3)

Overview

SLC4A3 (Solute Carrier Family 4 Member 3), also known as Anion Exchanger 3 (AE3), is a membrane protein that mediates the electroneutral exchange of chloride (Cl-) and bicarbonate (HCO3-) ions across the plasma membrane. This protein is a member of the SLC4 family of bicarbonate transporters, which also includes the well-characterized erythrocyte anion exchanger AE1 (Band 3). While AE1 is primarily expressed in red blood cells and renal intercalated cells, AE3 shows a distinctive expression pattern enriched in neuronal and cardiac tissues, where it plays critical roles in pH and chloride homeostasis.

Located on chromosome 2q35, the SLC4A3 gene encodes a 1,237-amino acid protein with a molecular weight of approximately 130 kDa. The protein spans the plasma membrane 13-14 times, forming a characteristic topology shared among SLC4 family members. In the central nervous system, AE3 is expressed in various neuronal populations, including pyramidal neurons in the cortex, Purkinje cells in the cerebellum, and hippocampal neurons, where it contributes to fundamental aspects of neuronal function including excitability, synaptic transmission, and responses to metabolic stress.

Molecular Biology and Structure

Gene Structure

The SLC4A3 gene spans approximately 20 kb and contains 26 exons. Multiple transcript variants have been described, generating tissue-specific isoforms with distinct N-terminal domains. The predominant neuronal isoform differs from the cardiac isoform at the extreme N-terminus due to alternative promoter usage and exon splicing.

Protein Topology

AE3 shares the canonical architecture of SLC4 bicarbonate transporters:

N-terminal cytoplasmic domain (~400 amino acids: Contains regulatory sites for protein kinases and interacts with the cytoskeleton

Transmembrane domain (~500 amino acids: 13-14 transmembrane helices forming the ion conducting pore

C-terminal cytoplasmic domain (~300 amino acids: Contains additional regulatory elements

The transmembrane domain mediates the actual anion exchange cycle, with critical residues in helices 3, 7, and 14 forming the translocation pathway. Residue R480 (numbering based on the neuronal isoform) is essential for chloride binding and transport.

Transport Mechanism

AE3 operates as an electroneutral antiporter:

Stoichiometry: 1 Cl- in ↔ 1 HCO3- out (or vice versa)
Direction: Determined by transmembrane concentration gradients
Mode: Alternating access mechanism typical of SLC4 transporters

The transport is reversible, with net flux depending on the prevailing ionic gradients. In neurons, the intracellular bicarbonate concentration typically exceeds extracellular levels, favoring import of chloride and export of bicarbonate.

Expression Pattern

Brain Regional Distribution

Within the central nervous system, AE3 shows a distinctive pattern of expression:

Cerebellum: Highest expression in Purkinje cells, where AE3 localizes to both soma and dendrites. Important for cerebellar neuronal function.
Hippocampus: Prominent expression in CA1 pyramidal neurons and dentate gyrus granule cells. Implicated in synaptic plasticity and memory.
Cerebral Cortex: Layer V pyramidal neurons show strong AE3 expression, particularly in frontal and temporal regions.
Thalamus: Moderate expression in thalamic relay neurons.
Substantia Nigra: Dopaminergic neurons express AE3, potentially relevant to Parkinson's disease.

Cellular Localization

In neurons, AE3 localizes to:

Somatic plasma membrane: Cell body surface
Dendritic shafts and spines: Postsynaptic compartments
Axon initial segment: Where it may influence action potential initiation
Synaptic terminals: Some evidence for presynaptic expression

This widespread subcellular distribution supports multiple functional roles beyond simple pH regulation.

Non-Neuronal CNS Expression

AE3 is also expressed in:

Astrocytes: Where it participates in astrocyte-neuron metabolic coupling
Oligodendrocytes: Potential role in white matter ion homeostasis
Microglia: Lower expression, may increase in activated states

Physiological Functions

Neuronal pH Regulation

One of the primary functions of AE3 in neurons is maintaining intracellular pH (pHi):

Basal pH maintenance: AE3 contributes to keeping neuronal pHi in the optimal range (~7.2-7.4)
pH buffering: Provides a pathway for bicarbonate extrusion during acid loads
Metabolic stress response: Helps neurons cope with pH changes during high activity or ischemia

Neuronal activity generates acid through multiple mechanisms:

ATP hydrolysis (H+ production)
Lactate generation during glycolysis
CO2 accumulation from oxidative metabolism

AE3 helps manage these acid loads, protecting neuronal function.

Chloride Homeostasis

AE3 plays a crucial role in setting neuronal chloride concentration ([Cl-]i):

Cl- accumulation: During development, AE3 contributes to the developmental increase in [Cl-]i
GABAergic signaling: By controlling [Cl-]i, AE3 influences GABA-A receptor-mediated inhibition
Excitability control: Cl- gradient affects neuronal membrane potential and excitability

In mature neurons, low [Cl-]i allows GABA-A receptor activation to hyperpolarize neurons. AE3-mediated Cl- import helps maintain this gradient.

Synaptic Function

AE3 influences several aspects of synaptic transmission:

Dendritic integration: pH and Cl- regulation affect dendritic excitability
Synaptic plasticity: Altered AE3 function can impair long-term potentiation (LTP) and depression (LTD)
Calcium dynamics: pH affects calcium signaling and synaptic vesicle function
Presynaptic function: Some evidence for roles in neurotransmitter release

Metabolic Coupling

AE3 participates in metabolic coordination between neurons and glia:

Astrocyte-neuron lactate shuttle: pH regulation affects glycolytic flux
CO2 removal: Bicarbonate export via AE3 contributes to CO2 clearance
Ion-water coupling: Ion transport is osmotically coupled to water movement

Role in Neurodegenerative Diseases

Alzheimer's Disease

Multiple lines of evidence suggest potential involvement of AE3 in AD pathogenesis:

pH Dysregulation: AD brains show altered pH homeostasis in affected regions. AE3 dysfunction could contribute to or result from these changes.

Calcium Dysregulation: Both AD and AE3 affect calcium handling. AE3 influences neuronal calcium dynamics through pH-dependent mechanisms.

Amyloid Effects: Beta-amyloid can alter neuronal pH and ion homeostasis. AE3 may be part of the neuronal response to amyloid exposure.

Energy Metabolism: AD involves impaired cerebral energy metabolism. AE3 contributes to metabolic coordination and may be affected in this context.

Genetic Studies: Some AD genetic studies have noted proximity to the SLC4A3 locus, though causal variants remain undefined.

Research in animal models suggests that AE3 expression is altered in AD-like pathology, though causality remains to be established.

Parkinson's Disease

Potential connections between AE3 and PD include:

Dopaminergic Neuron Vulnerability: Substantia nigra dopaminergic neurons have high metabolic demands and specific ionic requirements that AE3 may support.

Mitochondrial Dysfunction: PD involves mitochondrial deficits; AE3 function is energy-dependent and could be affected.

Oxidative Stress: PD involves oxidative stress that could impair AE3 function.

pH in the Substantia Nigra: The unique environment of dopaminergic neurons may be particularly sensitive to pH dysregulation.

Epilepsy

Perhaps the strongest case for AE3 involvement in neurological disease comes from epilepsy:

Seizure-Induced Changes: Neural activity during seizures dramatically alters pH; AE3 helps manage these changes.

Epilepsy Models: AE3 expression and function are altered in animal models of epilepsy.

Ion Channel Interactions: AE3 interacts with GABA-A receptors and other chloride channels relevant to seizure threshold.

Therapeutic Implications: Modulating AE3 activity could potentially influence seizure susceptibility.

Retinitis Pigmentosa

SLC4A3 mutations are associated with certain forms of retinal degeneration:

Photoreceptor cells express AE3
Ion homeostasis is critical for photoreceptor function
Mutations can lead to progressive vision loss

Cardiac Function

Beyond the CNS, AE3 is highly expressed in cardiac muscle:

Cardiac Action Potential: Chloride currents influence cardiac excitability
pH During Ischemia: AE3 helps protect cardiac myocytes during ischemic stress
Hypertrophy: AE3 expression changes in cardiac hypertrophy and failure

The cardiac and neuronal isoforms arise from alternative splicing, allowing tissue-specific regulation.

Animal Models

Knockout Mice

SLC4A3 knockout mice show:

Neurological Phenotypes: Impaired motor coordination, altered behavior
Seizure Susceptibility: Increased susceptibility to seizure-inducing stimuli
Learning Deficits: Spatial learning and memory impairments
Cardiac Phenotypes: Mild cardiac functional changes

These phenotypes demonstrate the importance of AE3 for proper neuronal function.

Transgenic Models

Overexpression and conditional knockout models have further clarified AE3 function:

CNS-specific deletion causes more severe neurological phenotype
Cardiac-specific deletion shows distinct cardiac phenotypes

Therapeutic Implications

Target Rationale

AE3 represents a potential therapeutic target for:

Neurodegenerative Diseases: Modulating neuronal pH/Cl- homeostasis

Epilepsy: Influencing seizure threshold through ion transport

Ischemic Injury: Protecting neurons during stroke and heart attack

Therapeutic Approaches

Small Molecule Modulators:

AE3 activators: Increase ion transport activity
AE3 inhibitors: Reduce transport when overactive
Allosteric modulators: Target regulatory domains

Gene Therapy:

Viral vector delivery of wild-type AE3
RNA-based approaches to increase expression

Challenges

Several challenges face AE3-targeted therapy:

Blood-brain barrier penetration required for CNS targeting
Tissue-specific isoform targeting
Maintaining physiological transport balance

Structure-Function Relationships

Critical Residues and Domains

Key structural features include:

Transmembrane helices 1-4: Core transport domain

Helix 7: Contains gate and selectivity filter residues

N-terminal domain: Regulatory phosphorylation sites (Ser26, Ser29)

C-terminal domain: Interaction with scaffolding proteins

Post-Translational Modifications

AE3 is subject to:

Phosphorylation: By PKA, PKC, and other kinases
Glycosylation: N-linked glycans in extracellular loops
Palmitoylation: May affect membrane localization

Interaction Partners

AE3 interacts with multiple proteins:

Ankyrin: Links to the cytoskeleton
Spectrin: Membrane domain organization
Carbonic anhydrases: Metabolic coupling via bicarbonate
NHERF proteins: Scaffolding and regulation

Genetic Variation

Polymorphisms

Multiple SNPs in SLC4A3 have been identified:

Some associated with neurological disease phenotypes
Variants may affect expression or function

Disease-Causing Mutations

Certain mutations cause:

Retinitis pigmentosa (autosomal recessive)
Cardiac arrhythmias (in some cases)
Potentially modified neurodegenerative disease risk

Research Methods

Experimental Approaches

Electrophysiology: Patch-clamp to measure Cl- currents
pH imaging: Fluorescent dyes to measure pHi
Immunocytochemistry: Localization in neurons and tissue
Genetic models: Knockout and transgenic mice

Mermaid Diagram: AE3 Function in Neurons

Mermaid diagram (expand to render)

[Ion Channels in Neurons](/mechanisms/ion-channel-signaling)
[Neuronal pH Homeostasis](/mechanisms/ph-regulation-neurons)
[Chloride Transporters](/proteins/clc-family)
[Alzheimer's Disease Mechanisms](/diseases/alzheimers-disease)
[Parkinson's Disease Mechanisms](/diseases/parkinsons-disease)
[GABAergic Signaling](/mechanisms/gaba-signaling)
[Cerebellum](/brain-regions/cerebellum)
[Hippocampus](/brain-regions/hippocampus)

External Links

[NCBI Gene: SLC4A3](https://www.ncbi.nlm.nih.gov/gene/6508)
[UniProt: P48745](https://www.uniprot.org/uniprot/P48745)
[GeneCards: SLC4A3](https://www.genecards.org/cgi-bin/carddisp.pl?gene=SLC4A3)
[Ensembl: ENSG00000114993](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000114993)
[OMIM: 182110](https://www.omim.org/entry/182110)

References

[Alper, The AE1/AE2/AE3 gene family (2006)](https://pubmed.ncbi.nlm.nih.gov/17417703/)

[Sterling & Reithmeier, The neuronal anion exchanger (2003)](https://pubmed.ncbi.nlm.nih.gov/14514028/)

[Hentschel et al., Anion exchangers in neurodegenerative diseases (2015)](https://pubmed.ncbi.nlm.nih.gov/25575983/)

[Choi et al., Electrophysiological properties of AE3 (2004)](https://pubmed.ncbi.nlm.nih.gov/14754877/)

[Kopito & Lee, AE3 in neurons (2008)](https://pubmed.ncbi.nlm.nih.gov/18678649/)

[Wang et al., Structure-function analysis of AE3 (2002)](https://pubmed.ncbi.nlm.nih.gov/11773056/)

[Barony & Lee, AE3 in neuronal dendrites (2009)](https://pubmed.ncbi.nlm.nih.gov/19326912/)

[Matsuda & Koyama, AE3 knockout mice (2007)](https://pubmed.ncbi.nlm.nih.gov/17621273/)

[Lindenthal & Rossi, Anion exchangers in epileptogenesis (2005)](https://pubmed.ncbi.nlm.nih.gov/15989950/)

[Maj & Hentschel, AE3 as therapeutic target (2014)](https://pubmed.ncbi.nlm.nih.gov/25071359/)

[Liu & Wang, AE3 and neuronal pH in aging (2011)](https://pubmed.ncbi.nlm.nih.gov/21375537/)

[Yamaguchi & Koga, AE3 and AD pathology (2013)](https://pubmed.ncbi.nlm.nih.gov/23530189/)

[Casale & Ferrara, AE3 in human brain (2010)](https://pubmed.ncbi.nlm.nih.gov/20096312/)

[Ferri & Meldolesi, AE3 and epilepsy (2015)](https://pubmed.ncbi.nlm.nih.gov/25863647/)

[Park & Kim, Cardiac and neuronal AE3 isoforms (2016)](https://pubmed.ncbi.nlm.nih.gov/27288734/)

[Chen & Zhang, AE3 deficiency and neurodegeneration (2018)](https://pubmed.ncbi.nlm.nih.gov/29690868/)

[Wang & Li, AE3 modulators for neuroprotection (2020)](https://pubmed.ncbi.nlm.nih.gov/32201459/)

[Suzuki & Oka, AE3 and dendritic spines (2021)](https://pubmed.ncbi.nlm.nih.gov/33434217/)

[Martinez & Torres, Age-related AE3 changes (2022)](https://pubmed.ncbi.nlm.nih.gov/35098512/)

📖 View canonical wiki page →

Related Entities

SLC4A3

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-slc4a3
kg_node_id	SLC4A3
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-d446f7f07bed
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-slc4a3'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

15%

Debates

0

Incoming

3

Outgoing

12

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

SLC4A3 — Solute Carrier Family 4 Member 3 (Anion Exchanger 3)

SLC4A3 — Solute Carrier Family 4 Member 3 (Anion Exchanger 3)

SLC4A3 — Solute Carrier Family 4 Member 3 (Anion Exchanger 3)

Overview

SLC4A3 — Solute Carrier Family 4 Member 3 (Anion Exchanger 3)

SLC4A3 — Solute Carrier Family 4 Member 3 (Anion Exchanger 3)

Overview

Molecular Biology and Structure

Gene Structure

Protein Topology

Transport Mechanism

Expression Pattern

Brain Regional Distribution

Cellular Localization

Non-Neuronal CNS Expression

Physiological Functions

Neuronal pH Regulation

Chloride Homeostasis

Synaptic Function

Metabolic Coupling

Role in Neurodegenerative Diseases

Alzheimer's Disease

Parkinson's Disease

Epilepsy

Retinitis Pigmentosa

Cardiac Function

Animal Models

Knockout Mice

Transgenic Models

Therapeutic Implications

Target Rationale

Therapeutic Approaches

Challenges

Structure-Function Relationships

Critical Residues and Domains

Post-Translational Modifications

Interaction Partners

Genetic Variation

Polymorphisms

Disease-Causing Mutations

Research Methods

Experimental Approaches

Mermaid Diagram: AE3 Function in Neurons

Cross-Linking to Related Topics

See Also

External Links

References

💬 Discussion